Cargando…

External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy

OBJECTIVE: We previously developed genitourinary (GU) cancer-specific scoring system for prediction of survival in patients with bone metastasis (the Bone-Fujimoto-Owari-Miyake [B-FOM] scoring model) based on five prognostic factors: the type of primary tumor (prostate cancer (PCa) vs renal cell car...

Descripción completa

Detalles Bibliográficos
Autores principales: Owari, Takuya, Miyake, Makito, Nakai, Yasushi, Tanaka, Nobumichi, Itami, Yoshitaka, Hirao, Shuya, Momose, Hitoshi, Nakagawa, Yoshinori, Iida, Kouta, Maesaka, Fumisato, Shimizu, Takuto, Iemura, Yusuke, Matsumoto, Yoshihiro, Kuwada, Masaomi, Otani, Takeshi, Otsuka, Kenji, Okajima, Eijiro, Hosokawa, Yukinari, Okamura, Ryosuke, Fujimoto, Kiyohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770480/
https://www.ncbi.nlm.nih.gov/pubmed/33384916
http://dx.doi.org/10.1016/j.jbo.2020.100344
_version_ 1783629518557151232
author Owari, Takuya
Miyake, Makito
Nakai, Yasushi
Tanaka, Nobumichi
Itami, Yoshitaka
Hirao, Shuya
Momose, Hitoshi
Nakagawa, Yoshinori
Iida, Kouta
Maesaka, Fumisato
Shimizu, Takuto
Iemura, Yusuke
Matsumoto, Yoshihiro
Kuwada, Masaomi
Otani, Takeshi
Otsuka, Kenji
Okajima, Eijiro
Hosokawa, Yukinari
Okamura, Ryosuke
Fujimoto, Kiyohide
author_facet Owari, Takuya
Miyake, Makito
Nakai, Yasushi
Tanaka, Nobumichi
Itami, Yoshitaka
Hirao, Shuya
Momose, Hitoshi
Nakagawa, Yoshinori
Iida, Kouta
Maesaka, Fumisato
Shimizu, Takuto
Iemura, Yusuke
Matsumoto, Yoshihiro
Kuwada, Masaomi
Otani, Takeshi
Otsuka, Kenji
Okajima, Eijiro
Hosokawa, Yukinari
Okamura, Ryosuke
Fujimoto, Kiyohide
author_sort Owari, Takuya
collection PubMed
description OBJECTIVE: We previously developed genitourinary (GU) cancer-specific scoring system for prediction of survival in patients with bone metastasis (the Bone-Fujimoto-Owari-Miyake [B-FOM] scoring model) based on five prognostic factors: the type of primary tumor (prostate cancer (PCa) vs renal cell carcinoma (RCC) and PCa vs urothelial carcinoma (UC)), poor performance status (PS), visceral metastasis, high Glasgow-prognostic score (GPS), elevated neutrophil-to-lymphocyte ratio (NLR). The aim of this study was to externally validate and further improve the performance of the B-FOM score. METHODS: The external validation cohort comprised 309 patients with GU cancer with bone metastasis from multiple institutions. Clinical factors were analyzed using Kaplan-Meier method and COX regression hazard model. Performance of a modified B-FOM score was compared to that of other scoring models by the Kaplan-Meier method and the area under the curve (AUC) of receiver operating characteristic curves. RESULTS: The median follow-up period of development and validation cohort were 25 and 17 months, respectively. Kaplan-Meier curve demonstrated that the type of primary tumor (RCC and UC vs PCa), poor PS, presence of visceral metastasis, high GPS, elevated NLR were significantly associated with shorter cancer-specific survival. Risk groups were successfully stratified by the modified B-FOM score classification. Moreover, the AUC of the modified B-FOM scoring model for predicting mortality at 6, 12, and 24 months were 0.895, 0.856, and 0.815, respectively, which were the highest among evaluated models. CONCLUSIONS: The B-FOM scoring model is a simple and accurate prediction tool. By using this scoring model at the time of the diagnosis of bone metastasis in patients with GU cancers, an individualized optimal treatment strategy can be selected.
format Online
Article
Text
id pubmed-7770480
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77704802020-12-30 External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy Owari, Takuya Miyake, Makito Nakai, Yasushi Tanaka, Nobumichi Itami, Yoshitaka Hirao, Shuya Momose, Hitoshi Nakagawa, Yoshinori Iida, Kouta Maesaka, Fumisato Shimizu, Takuto Iemura, Yusuke Matsumoto, Yoshihiro Kuwada, Masaomi Otani, Takeshi Otsuka, Kenji Okajima, Eijiro Hosokawa, Yukinari Okamura, Ryosuke Fujimoto, Kiyohide J Bone Oncol Research Article OBJECTIVE: We previously developed genitourinary (GU) cancer-specific scoring system for prediction of survival in patients with bone metastasis (the Bone-Fujimoto-Owari-Miyake [B-FOM] scoring model) based on five prognostic factors: the type of primary tumor (prostate cancer (PCa) vs renal cell carcinoma (RCC) and PCa vs urothelial carcinoma (UC)), poor performance status (PS), visceral metastasis, high Glasgow-prognostic score (GPS), elevated neutrophil-to-lymphocyte ratio (NLR). The aim of this study was to externally validate and further improve the performance of the B-FOM score. METHODS: The external validation cohort comprised 309 patients with GU cancer with bone metastasis from multiple institutions. Clinical factors were analyzed using Kaplan-Meier method and COX regression hazard model. Performance of a modified B-FOM score was compared to that of other scoring models by the Kaplan-Meier method and the area under the curve (AUC) of receiver operating characteristic curves. RESULTS: The median follow-up period of development and validation cohort were 25 and 17 months, respectively. Kaplan-Meier curve demonstrated that the type of primary tumor (RCC and UC vs PCa), poor PS, presence of visceral metastasis, high GPS, elevated NLR were significantly associated with shorter cancer-specific survival. Risk groups were successfully stratified by the modified B-FOM score classification. Moreover, the AUC of the modified B-FOM scoring model for predicting mortality at 6, 12, and 24 months were 0.895, 0.856, and 0.815, respectively, which were the highest among evaluated models. CONCLUSIONS: The B-FOM scoring model is a simple and accurate prediction tool. By using this scoring model at the time of the diagnosis of bone metastasis in patients with GU cancers, an individualized optimal treatment strategy can be selected. Elsevier 2020-12-13 /pmc/articles/PMC7770480/ /pubmed/33384916 http://dx.doi.org/10.1016/j.jbo.2020.100344 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Owari, Takuya
Miyake, Makito
Nakai, Yasushi
Tanaka, Nobumichi
Itami, Yoshitaka
Hirao, Shuya
Momose, Hitoshi
Nakagawa, Yoshinori
Iida, Kouta
Maesaka, Fumisato
Shimizu, Takuto
Iemura, Yusuke
Matsumoto, Yoshihiro
Kuwada, Masaomi
Otani, Takeshi
Otsuka, Kenji
Okajima, Eijiro
Hosokawa, Yukinari
Okamura, Ryosuke
Fujimoto, Kiyohide
External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy
title External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy
title_full External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy
title_fullStr External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy
title_full_unstemmed External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy
title_short External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy
title_sort external validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified b-fom scoring model): comparison with other scoring models in terms of accuracy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770480/
https://www.ncbi.nlm.nih.gov/pubmed/33384916
http://dx.doi.org/10.1016/j.jbo.2020.100344
work_keys_str_mv AT owaritakuya externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT miyakemakito externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT nakaiyasushi externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT tanakanobumichi externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT itamiyoshitaka externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT hiraoshuya externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT momosehitoshi externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT nakagawayoshinori externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT iidakouta externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT maesakafumisato externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT shimizutakuto externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT iemurayusuke externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT matsumotoyoshihiro externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT kuwadamasaomi externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT otanitakeshi externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT otsukakenji externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT okajimaeijiro externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT hosokawayukinari externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT okamuraryosuke externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy
AT fujimotokiyohide externalvalidationofagenitourinarycancerspecificprognosticscoringsystemtopredictsurvivalforpatientswithbonemetastasismodifiedbfomscoringmodelcomparisonwithotherscoringmodelsintermsofaccuracy